Literature DB >> 28274637

Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.

Inna G Ovsyannikova1, Beth R Larrabee2, Daniel J Schaid2, Gregory A Poland3.   

Abstract

Identifying genetic polymorphisms that explain variations in humoral immunity to live measles virus vaccine is of great interest. Immunoglobulin GM (heavy chain) and KM (light chain) allotypes are genetic markers known to be associated with susceptibility to several infectious diseases. We assessed associations between GM and KM genotypes and measles vaccine humoral immunity (neutralizing antibody titers) in a combined cohort (n=1796) of racially diverse healthy individuals (age 18-41years). We did not discover any significant associations between GM and/or KM genotypes and measles vaccine-induced neutralizing antibody titers. African-American subjects had higher neutralizing antibody titers than Caucasians (1260mIU/mL vs. 740mIU/mL, p=7.10×10-13), and those titers remained statistically significant (p=1.68×10-09) after adjusting for age at enrollment and time since last vaccination. There were no statistically significant sex-specific differences in measles-induced neutralizing antibody titers in our study (p=0.375). Our data indicate a surprising lack of evidence for an association between GM and KM genotypes and measles-specific neutralizing antibody titers, despite the importance of these immune response genes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibodies; Genetic association studies; Immunoglobulin Gm allotypes; Immunoglobulin Km allotypes; Immunoglobulin allotypes; Immunoglobulins; Measles; Measles vaccine; Measles virus; Measles-Mumps-Rubella vaccine; Neutralizing

Mesh:

Substances:

Year:  2017        PMID: 28274637      PMCID: PMC5587382          DOI: 10.1016/j.vaccine.2017.02.046

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  20 in total

Review 1.  Immunoglobulin GM and KM allotypes and vaccine immunity.

Authors:  J P Pandey
Journal:  Vaccine       Date:  2000-11-08       Impact factor: 3.641

2.  The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

3.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

4.  GM allotypes and IgG subclass concentrations in blacks.

Authors:  J P Pandey; J C Gunsolley; J G Tew; H A Schenkein
Journal:  Exp Clin Immunogenet       Date:  1996

5.  Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.

Authors:  Emily A Voigt; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Beth R Larrabee; Daniel J Schaid; Gregory A Poland
Journal:  Vaccine       Date:  2016-08-30       Impact factor: 3.641

6.  Genome-wide association study of antibody response to smallpox vaccine.

Authors:  Inna G Ovsyannikova; Richard B Kennedy; Megan O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-04-25       Impact factor: 3.641

7.  Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.

Authors:  David C Montefiori; Barbara Metch; M Juliana McElrath; Steve Self; Kent J Weinhold; Lawrence Corey
Journal:  J Infect Dis       Date:  2004-10-28       Impact factor: 5.226

8.  Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine.

Authors:  Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

Review 9.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2008-05-07
View more
  1 in total

1.  Introduction.

Authors:  Stephen J Streatfield; Jerzy Karczewski; Vidadi Yusibov
Journal:  Vaccine       Date:  2017-08-18       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.